Implication of ultrasound contrast‐enhancement of carotid plaques in prevalence of acute coronary syndrome and occurrence of cardiovascular outcomes

Purpose Ultrasonographic contrast enhancement of carotid plaque (CECP) has been used to detect neovascularization of vasa vasorum and plaque. However, it is uncertain whether CECP can provide risk stratification of coronary artery disease (CAD). This study aimed to evaluate the relationship between...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical ultrasound Vol. 46; no. 7; pp. 461 - 466
Main Authors Choi, Sang‐Woong, Kim, Hyungseop, Kim, In‐Cheol, Lee, Cheol‐Hyun, Hwang, Jongmin, Park, Hyoung‐Seob, Cho, Yun‐Kyeong, Yoon, Hyuck‐Jun, Nam, Chang‐Wook, Han, Seongwook, Hur, Seung‐Ho
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.09.2018
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose Ultrasonographic contrast enhancement of carotid plaque (CECP) has been used to detect neovascularization of vasa vasorum and plaque. However, it is uncertain whether CECP can provide risk stratification of coronary artery disease (CAD). This study aimed to evaluate the relationship between CECP and manifestations of acute coronary syndrome (ACS) in established CAD patients and to explore the prognostic implication of CECP for cardiovascular (CV) clinical outcomes. Methods A medical record review revealed that contrast‐enhanced ultrasonography was performed to evaluate carotid atherosclerosis in 209 coronary artery‐stented and 105 non‐stented patients. The rate of ACS manifestations was compared depending on contrast uptake patterns: grade 0, absent; grade 1, dot; and grade 2, diffuse pattern. CV primary outcomes were assessed during a mean 7.6 months of follow‐up. Results Male sex, smoking, history of old myocardial infarction, intensive medications, and a favorable lipid profile were common in the stented versus non‐stented group. Patients with grade 2 CECP had a higher rate of ACS, greater plaque thickness, and class I‐II of Gray‐Weale plaque echogenicity. During follow‐up, 10 coronary revascularizations (nine ACSs), six strokes, and four heart failures occurred. Grade 2 CECP was more closely related with CV primary outcomes and showed a tendency toward more acute CV outcomes. Conclusion ACS manifestations were proportionate to CECP grade. Diffuse CECP uptake could be a risk factor for acute CV outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0091-2751
1097-0096
DOI:10.1002/jcu.22638